Scientific Sessions 2024  /  GLP-1RAs and Beyond: Incretin Analogues and a New Frontier in Cardiovascular Therapeutics
Logo

American Heart Association

Scientific Sessions 2024

GLP-1RAs and Beyond: Incretin Analogues and a New Frontier in Cardiovascular Therapeutics

Main Event

Main Event II

Nov 17th , 09:45 AM - 11:00 AM

Showing 11 Results.

09 : 45 AM

How are incretins PIONEERing metabolic care? Mechanisms of weight loss and risk factor reduction with incretin analogues

Nauck Michael,  Drucker Daniel,  Pratley Richard

Final Pr. ID: -

Authors:  Nauck Michael,  Drucker Daniel,  Pratley Richard

09 : 45 AM

The cardiovascular benefits of incretin analogues: Suggestions of indirect and direct vascular effects

Mcmurray John,  Sattar Naveed

Final Pr. ID: -

Authors:  Mcmurray John,  Sattar Naveed

09 : 45 AM

Going with the FLOW: Understanding the renal effects of GLP-1RA therapy

Tuttle Katherine,  Rangaswami Janani

Final Pr. ID: -

Authors:  Tuttle Katherine,  Rangaswami Janani

09 : 45 AM

How do we SELECT incretin analogues and SUSTAIN their impact? Clinical approaches for short and long-term obesity care

Jastreboff Ania,  Lingvay Ildiko

Final Pr. ID: -

Authors:  Jastreboff Ania,  Lingvay Ildiko

09 : 45 AM

Access and Equity: real world implications of the coverage and cost of incretin mimetics

Powell-wiley Tiffany,  Essien Utibe

Final Pr. ID: -

Authors:  Powell-wiley Tiffany,  Essien Utibe

09 : 45 AM

Patient Interview

Ndumele Chiadi,  Taub Pam

Final Pr. ID: -

Authors:  Ndumele Chiadi,  Taub Pam

09 : 45 AM

Panel Discussion

Nauck Michael,  Drucker Daniel,  Pratley Richard

Final Pr. ID: -

Authors:  Nauck Michael,  Drucker Daniel,  Pratley Richard

09 : 45 AM

Panel Discussion

Powell-wiley Tiffany

Final Pr. ID: -

Authors:  Powell-wiley Tiffany

09 : 45 AM

Panel Discussion

Tuttle Katherine

Final Pr. ID: -

Authors:  Tuttle Katherine

09 : 45 AM

Panel Discussion

Mcmurray John

Final Pr. ID: -

Authors:  Mcmurray John

09 : 45 AM

Panel Discussion

Jastreboff Ania

Final Pr. ID: -

Authors:  Jastreboff Ania

09 : 45 AM

Access and Equity: real world implications of the coverage and cost of incretin mimetics

Powell-wiley Tiffany,  Essien Utibe

Final Pr. ID: -

Authors:  Powell-wiley Tiffany,  Essien Utibe

1

09 : 45 AM

Going with the FLOW: Understanding the renal effects of GLP-1RA therapy

Tuttle Katherine,  Rangaswami Janani

Final Pr. ID: -

Authors:  Tuttle Katherine,  Rangaswami Janani

2

09 : 45 AM

How are incretins PIONEERing metabolic care? Mechanisms of weight loss and risk factor reduction with incretin analogues

Nauck Michael,  Drucker Daniel,  Pratley Richard

Final Pr. ID: -

Authors:  Nauck Michael,  Drucker Daniel,  Pratley Richard

1

09 : 45 AM

How do we SELECT incretin analogues and SUSTAIN their impact? Clinical approaches for short and long-term obesity care

Jastreboff Ania,  Lingvay Ildiko

Final Pr. ID: -

Authors:  Jastreboff Ania,  Lingvay Ildiko

1

09 : 45 AM

Panel Discussion

Nauck Michael,  Drucker Daniel,  Pratley Richard

Final Pr. ID: -

Authors:  Nauck Michael,  Drucker Daniel,  Pratley Richard

1

09 : 45 AM

Panel Discussion

Powell-wiley Tiffany

Final Pr. ID: -

Authors:  Powell-wiley Tiffany

2

09 : 45 AM

Panel Discussion

Tuttle Katherine

Final Pr. ID: -

Authors:  Tuttle Katherine

1

09 : 45 AM

Panel Discussion

Mcmurray John

Final Pr. ID: -

Authors:  Mcmurray John

2

09 : 45 AM

Panel Discussion

Jastreboff Ania

Final Pr. ID: -

Authors:  Jastreboff Ania

2

09 : 45 AM

Patient Interview

Ndumele Chiadi,  Taub Pam

Final Pr. ID: -

Authors:  Ndumele Chiadi,  Taub Pam

1

09 : 45 AM

The cardiovascular benefits of incretin analogues: Suggestions of indirect and direct vascular effects

Mcmurray John,  Sattar Naveed

Final Pr. ID: -

Authors:  Mcmurray John,  Sattar Naveed

2